Investor Relations; Private Equity - Analyst​/Sr. Analyst

Investor Relations (Private Equity) – Analyst/Sr. Analyst

Base pay range: $90,000.00/yr – $/yr

Location: New York, NY, USA

ARCHIMED is not just another investment firm. With offices across Europe, the U.S., and Asia, its singular focus is on healthcare. That concentration is by design: combining operational, medical, scientific, and financial depth lets ARCHIMED act not just as capital, but as a true partner.

We channel our efforts into Biopharma Products, Consumer Health, Healthcare IT, In Vitro Diagnostics, Life Science Tools & Biologic Services, Med Tech, and Pharma Services. We help companies internationalize, acquire, innovate, and expand.

ARCHIMED manages €8 billion across its funds, including the largest healthcare‑only private equity fund ever raised by a European‑based general partner. Its MED I, MED II, and MED Platform I are top‑decile performers in their vintages (per Preqin). From day one, ARCHIMED has embraced impact investing, both directly and through its EURÊKA Foundation.

Our team is international (French, British, German, Polish, Canadian, U.S., Japanese, etc.) and deeply cross‑disciplinary, bringing together experience in investing, medicine, operations, strategy, and science. We include alumni of INSEAD, Berkeley, Wharton, Georgetown, Bocconi, HEC Paris, Ponts et Chaussées, ESSEC, Imperial, Dartmouth, and more. Our collective backgrounds span private equity (3i, Siparex, USS, Barings, Capiton, KKR, Partners Group), consulting (A.T. Kearney, Bain, McKinsey), M&A (Lazard, EY, KPMG, PwC), and industry (Biotronik, Cerba, pharmacy, veterinary).

You will work side by side with the Head of Investor Relations and senior leadership to conceive, plan, and execute fundraisings. Your tasks will include:

• Market analysis
• Design and production of marketing materials (VDR, pitch decks, PPM, DDQ, etc.)
• Legal structuring
• Coordinating with third‑party providers and forming partnerships

Beyond execution, your role is narrative. You must help tell ARCHIMED's story, who we are, why we matter, how we generate value, in a way that resonates with investors and withstands scrutiny. You will attend investor events, represent ARCHIMED, and work roadshows.

You will run the mechanics of the IR program: quarterly and annual reporting for funds and co‑investments, LP queries, secondary transfers, and the like (in close collaboration with Finance, Impact, and Investment teams). You will lead the planning and execution of our Annual General Meeting in coordination with the Communications team.

You’ll support our co‑investment programme and help structure and execute GP‑led secondaries when appropriate. You'll work across deal teams and with external investors to spot, shape, and deliver these opportunities.

• Deep experience in IR and fundraising with institutional investors
• Financial sophistication, ability to use models, frameworks, and diligence with ease
• Knowledge of market structures, legal frameworks, and industry conventions
• Curiosity and discipline in data gathering and interpretation
• Capacity to sift priorities in a fast‑moving environment
• Clarity of communication, simplifying without oversimplifying
• Collaborative mindset, soliciting input, engaging thoughtfully, showing integrity
• Sales instincts in financial services / PE: prospecting, pipeline building, tailoring propositions
• Firm grasp of fund structuring, performance metrics, and portfolio finance
• Creativity in spotting new capital sources and growing AUM
• At minimum a degree in Finance, Economics, or Business
• Ability to independently build and manage relationships
• Excellent Excel and PowerPoint skills
• Entrepreneurial orientation, building rather than maintaining
• Alignment with cultural values: inclusion, meritocracy, accountability, client focus, trust

• Proven track record in investor relations or fundraising, ideally within private equity, investment banking, or adjacent financial services.
• Experience building and managing institutional investor relationships, from initial outreach through long‑term partnership.
• Advanced…